Statement of Deviation not applicable as no fresh funds raised

Compliance View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-1.7%Reaction day

₹1.74

prior close

₹1.70

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-2.8%+1.0% vs market

Pharmaceuticals peers, median of 172sector-2.5%+0.7% vs sector

On the reaction day the stock moved 1.0 pts more than Nifty Microcap 250 and 0.7 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-1.7-2.8+1.0-2.5+0.7

Next day

-2.9-2.5-0.4-2.6-0.3

+0.6-1.7+2.2-2.5+3.1

-3.4-1.5-2.0-2.5-0.9

-3.4-0.8-2.7-2.5-0.9

-4.0-2.4-1.6-3.2-0.9

-2.9-3.4+0.5-4.4+1.5

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 172Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Vivanza Biosciences has informed BSE that the Statement of Deviation or Variation under SEBI Regulation 32 is not applicable. The company confirms it has not raised any fresh funds through public issue, rights issue, preferential issue, or QIP, so the disclosure requirement for tracking use of raised funds does not apply. This is a routine quarterly compliance submission signed by Managing Director Jayendra Mehta.

Likely market impact

Routine compliance filing with no material impact on shareholders or the stock. Simply confirms no fresh capital was raised through specified routes.